Mechanisms of airway remodeling

Chest

Volumn 144, Issue 3, 2013, Pages 1026-1032

  Hirota, Nobuaki ^a   Martin, James G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; EOTAXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUTICASONE; IMATINIB; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MONTELUKAST; OMALIZUMAB; PEPTIDOLEUKOTRIENE; PLATELET DERIVED GROWTH FACTOR; TIOTROPIUM BROMIDE; TRANSFORMING GROWTH FACTOR BETA;

AIRWAY OBSTRUCTION; AIRWAY REMODELING; AIRWAY SMOOTH MUSCLE CELL; ALLERGIC ASTHMA; ARTICLE; ASTHMA; BRONCHIECTASIS; BRONCHOSCOPY; CHRONIC MYELOID LEUKEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DRUG MEGADOSE; GOBLET CELL; GOBLET CELL METAPLASIA; HUMAN; METAPLASIA; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SMOOTH MUSCLE FIBER; SQUAMOUS CELL METAPLASIA; TH2 CELL;

EID: 84884331071     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-3073     Document Type: Article

References (58)

1. Grainge CL, Lau LC, Ward JA, et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med. 2011 ; 364 (21): 2006-2015.
2. Payne DN, Rogers AV, Adelroth E, et al. Early thickening of the reticular basement membrane in children with diffi cult asthma. Am J Respir Crit Care Med. 2003 ; 167 (1): 78-82.
3. Regamey N, Ochs M, Hilliard TN, et al. Increased airway smooth muscle mass in children with asthma, cystic fi brosis, and non-cystic fi brosis bronchiectasis. Am J Respir Crit Care Med. 2008 ; 177 (8): 837-843.
4. James AL, Bai TR, Mauad T, et al. Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. Eur Respir J. 2009 ; 34 (5): 1040-1045.
5. James AL, Elliot JG, Jones RL, et al. Airway smooth muscle hypertrophy and hyperplasia in asthma. Am J Respir Crit Care Med. 2012 ; 185 (10): 1058-1064.
6. Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK. Myofi broblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol. 1997 ; 16 (6): 664-673.
7. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011 ; 365 (17): 1567-1575.
8. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis. 1993 ; 147 (2): 405-410.
9. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two infl ammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999; 160(3): 1001-1008.
10. Woodruff PG, Khashayar R, Lazarus SC, et al. Relationship between airway infl ammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol. 2001 ; 108 (5): 753-758.
11. Pepe C, Foley S, Shannon J, et al. Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol. 2005 ; 116 (3): 544-549.
12. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978 ; 298 (23): 1277-1281.
13. Contoli M, Baraldo S, Marku B, et al. Fixed airfl ow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol. 2010 ; 125 (4): 830-837.
14. Tiddens HA, Koopman LP, Lambert RK, et al. Cartilaginous airway wall dimensions and airway resistance in cystic fi brosis lungs. Eur Respir J. 2000 ; 15 (4): 735-742.
15. Wiggs BR, Hrousis CA, Drazen JM, Kamm RD. On the mechanism of mucosal folding in normal and asthmatic airways. J Appl Physiol. 1997 ; 83 (6): 1814-1821.
16. de Jong PA, Müller NL, Paré PD, Coxson HO. Computed tomographic imaging of the airways: relationship to structure and function. Eur Respir J. 2005 ; 26 (1): 140-152.
17. Williamson JP, McLaughlin RA, Noffsinger WJ, et al. Elastic properties of the central airways in obstructive lung diseases measured using anatomical optical coherence tomography. Am J Respir Crit Care Med. 2011; 183(5): 612-619.
18. Yick CY, von der Thüsen JH, Bel EH, Sterk PJ, Kunst PW. In vivo imaging of the airway wall in asthma: fi bered confocal fl uorescence microscopy in relation to histology and lung function. Respir Res. 2011 ; 12 (1): 85.
19. Olivieri D, Chetta A, Del Donno M, et al. Effect of shortterm treatment with low-dose inhaled fl uticasone propionate on airway infl ammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med. 1997; 155 (6): 1864-1871.
20. Chetta A, Zanini A, Foresi A, et al. Vascular component of airway remodeling in asthma is reduced by high dose of fl uticasone. Am J Respir Crit Care Med. 2003 ; 167 (5): 751-757.
21. Bergeron C, Hauber HP, Gotfried M, et al. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofl uoroalkane-fl unisolide. J Allergy Clin Immunol. 2005 ; 116 (5): 983-989.
22. Vanacker NJ, Palmans E, Kips JC, Pauwels RA. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med. 2001 ; 163 (3 pt 1): 674-679.
23. Orsida BE, Ward C, Li X, et al. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med. 2001 ; 164 (1): 117-121.
24. Tamaoka M, Hassan M, McGovern T, et al. The epidermal growth factor receptor mediates allergic airway remodelling in the rat. Eur Respir J. 2008 ; 32 (5): 1213-1223.
25. Henderson WR Jr, Chiang GK, Tien YT, Chi EY. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med. 2006 ; 173 (7): 718-728.
26. Gosens R, Bos IS, Zaagsma J, Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med. 2005; 171(10): 1096-1102.
27. Kang JY, Rhee CK, Kim JS, et al. Effect of tiotropium bromide on airway remodeling in a chronic asthma model. Ann Allergy Asthma Immunol. 2012 ; 109 (1): 29-35.
28. Leclere M, Lavoie-Lamoureux A, Joubert P, et al. Corticosteroids and antigen avoidance decrease airway smooth muscle mass in an equine asthma model. Am J Respir Cell Mol Biol. 2012 ; 47 (5): 589-596.
29. Stoltz DA, Meyerholz DK, Pezzulo AA, et al. Cystic fi brosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med. 2010 ; 2 (29): 29ra31.
30. Kanazawa H, Asai K, Hirata K, Yoshikawa J. Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest. 2002 ; 122 (1): 166-170.
31. Zanini A, Chetta A, Saetta M, et al. Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment. Thorax. 2009 ; 64 (12): 1019-1024.
32. Pera T, Zuidhof A, Valadas J, et al. Tiotropium inhibits pulmonary infl ammation and remodelling in a guinea pig model of COPD. Eur Respir J. 2011 ; 38 (4): 789-796.
33. Gauvreau GM, Boulet LP, Cockcroft DW, et al. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med. 2011 ; 183 (8): 1007-1014.
34. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009 ; 360 (10): 973-984.
35. Rodrigo GJ, Neffen H, Castro-Rodriguez JA. Effi cacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. Chest. 2011 ; 139 (1): 28-35.
36. Le Cras TD, Acciani TH, Mushaben EM, et al. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. Am J Physiol Lung Cell Mol Physiol. 2011 ; 300 (3): L414-L421.
37. Hardie WD, Le Cras TD, Jiang K, Tichelaar JW, Azhar M, Korfhagen TR. Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fi brosis. Am J Physiol Lung Cell Mol Physiol. 2004; 286(4): L741-L749.
38. Shiomi T, Tschumperlin DJ, Park JA, et al. TNF-a-converting enzyme/a disintegrin and metalloprotease-17 mediates mechanotransduction in murine tracheal epithelial cells. Am J Respir Cell Mol Biol. 2011 ; 45 (2): 376-385.
39. Rhee CK, Kim JW, Park CK, et al. Effect of imatinib on airway smooth muscle thickening in a murine model of chronic asthma. Int Arch Allergy Immunol. 2011 ; 155 (3): 243-251.
40. Simeone-Penney MC, Severgnini M, Rozo L, Takahashi S, Cochran BH, Simon AR. PDGF-induced human airway smooth muscle cell proliferation requires STAT3 and the small GTPase Rac1. Am J Physiol Lung Cell Mol Physiol. 2008 ; 294 (4): L698-L704.
41. Hirota JA, Ask K, Farkas L, et al. In vivo role of plateletderived growth factor-BB in airway smooth muscle proliferation in mouse lung. Am J Respir Cell Mol Biol. 2011 ; 45 (3): 566-572.
42. Redington AE, Madden J, Frew AJ, et al. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fl uid. Am J Respir Crit Care Med. 1997 ; 156 (2 pt 1): 642-647.
43. Podowski M, Calvi C, Metzger S, et al. Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. J Clin Invest. 2012; 122(1): 229-240.
44. Wegmann M, Göggel R, Sel S, et al. Effects of a low-molecularweight CCR-3 antagonist on chronic experimental asthma. Am J Respir Cell Mol Biol. 2007 ; 36 (1): 61-67.
45. Johnson PR, Roth M, Tamm M, et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med. 2001 ; 164 (3): 474-477.
46. Joubert P, Hamid Q. Role of airway smooth muscle in airway remodeling. J Allergy Clin Immunol. 2005 ; 116 (3): 713-716.
47. Hirota N, Risse PA, Novali M, et al. Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells. FASEB J. 2012 ; 26 (4): 1704-1716.
48. Parameswaran K, Cox G, Radford K, Janssen LJ, Sehmi R, O'Byrne PM. Cysteinyl leukotrienes promote human airway smooth muscle migration. Am J Respir Crit Care Med. 2002 ; 166 (5): 738-742.
49. Panettieri RA, Tan EM, Ciocca V, Luttmann MA, Leonard TB, Hay DW. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol. 1998 ; 19 (3): 453-461.
50. Takeda N, Sumi Y, Préfontaine D, et al. Epithelium-derived chemokines induce airway smooth muscle cell migration. Clin Exp Allergy. 2009 ; 39 (7): 1018-1026.
51. Monzon ME, Forteza RM, Casalino-Matsuda SM. MCP-1/ CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium. Am J Physiol Lung Cell Mol Physiol. 2011 ; 300 (2): L204-L215.
52. Chang Y, Al-Alwan L, Risse PA, et al. TH17 cytokines induce human airway smooth muscle cell migration. J Allergy Clin Immunol. 2011 ; 127 (4): 1046-1053.
53. Booth BW, Adler KB, Bonner JC, Tournier F, Martin LD. Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. Am J Respir Cell Mol Biol. 2001 ; 25 (6): 739-743.
54. Risse PA, Jo T, Suarez F, et al. Interleukin-13 inhibits proliferation and enhances contractility of human airway smooth muscle cells without change in contractile phenotype. Am J Physiol Lung Cell Mol Physiol. 2011 ; 300 (6): L958-L966.
55. Kanazawa H, Nomura S, Asai K. Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients. Chest. 2007 ; 131 (4): 1035-1041.
56. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fi broblasts by transforming growth factor beta. J Exp Med. 1987 ; 165 (1): 251-256.
57. Xie S, Sukkar MB, Issa R, Khorasani NM, Chung KF. Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta. Am J Physiol Lung Cell Mol Physiol. 2007 ; 293 (1): L245-L253.
58. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002 ; 360 (9347): 1715-1721.